1164500-72-4
Chemical Structure
ML 145
- CAS No.: 1164500-72-4
- Formula:C24H22N2O5S2
- Molecular Weight:482.57
IUPAC Name: 2-hydroxy-4-(4-((Z)-5-((E)-2-methyl-3-phenylallylidene)-4-oxo-2-thioxothiazolidin-3-yl)butanamido)benzoic acid
InChIKey: COFMYJWNXSFLKQ-QIROLCGISA-N
SMILES: CC(/C=C(S1)/C(N(CCCC(NC2=CC(O)=C(C(O)=O)C=C2)=O)C1=S)=O)=C\C3=CC=CC=C3
Biological Activity: ML 145 is a selective and competitive human GPR35/CXCR8 antagonist with an IC50/EC50 of 20.1 nM. ML 145 has over 1000-fold more selective for GPR35 compared to GPR55 (IC50/EC50=21.7 μM)[1]. ML 145 has no significant activity for GPR35 at either rodent ortholog[2].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
ML 145 | 96.09% | ML 145 is a selective and competitive human GPR35/CXCR8 antagonist with an IC50/EC50 of 20.1 nM. ML 145 has over 1000-fold more selective for GPR35 compared to GPR55 (IC50/EC50=21.7 μM). ML 145 has no significant activity for GPR35 at either rodent ortholog. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
ML 145 (Standard) | ML 145 (Standard) is the analytical standard of ML 145 (HY-107536). This product is intended for research and analytical applications. ML 145 is a selective and competitive human GPR35/CXCR8 antagonist with an IC50/EC50 of 20.1 nM. ML 145 has over 1000-fold more selective for GPR35 compared to GPR55 (IC50/EC50=21.7 μM). ML 145 has no significant activity for GPR35 at either rodent ortholog. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
-
Similarity Score 0.69
HY-101510RF1063-0967 (Standard) -
Similarity Score 0.59
HY-66009REpalrestat (Standard) -
Similarity Score 0.54
HY-49597Pin1 modulator 1 -
Similarity Score 0.52
HY-47878WAY-300569 -
Similarity Score 0.52
HY-47877WAY-300570 -
Similarity Score 0.52
HY-149739WAY-620445 -
Similarity Score 0.50
HY-167242ZTB23(R) -
Similarity Score 0.50
HY-178292VHR-IN-3 -
Similarity Score 0.49
HY-151356Antibacterial agent 122 -
Explore the MedChemAI to find more analogs
References
- [1]. Heynen-Genel S, et al. Selective GPR35 Antagonists - Probes 1 & 2. National Center for Biotechnology Information (US); 2010-2010 Feb 28. [Content Brief]
- [2]. Laura Jenkins, et al. Antagonists of GPR35 display high species ortholog selectivity and varying modes of action. J Pharmacol Exp Ther. 2012 Dec;343(3):683-95. [Content Brief]